Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-20 Sale | 2026-07-21 8:50 pm | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 4,856 | $24.56 | $119,274 | 18,364 (Direct) | View |
| 2026-07-17 Sale | 2026-07-20 5:34 pm | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 3,065 | $25.21 | $77,259 | 3,506 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-20 Exercise | 2026-07-21 8:50 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 3,506 | $0.08 | 18,364 (Direct) | View |
| 2026-07-20 Exercise | 2026-07-21 8:50 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 1,350 | $1.91 | 18,364 (Direct) | View |
| 2026-07-20 Exercise | 2026-07-21 8:50 pm | N/A 2030-11-23 | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 4,856 | $0 | 18,364 (Direct) | View |
| 2026-07-17 Exercise | 2026-07-20 5:34 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 3,065 | $0.08 | 3,506 (Direct) | View |
| 2026-07-17 Exercise | 2026-07-20 5:34 pm | N/A 2030-11-23 | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 3,065 | $0 | 3,506 (Direct) | View |
Ownership | 2026-01-08 9:08 pm | N/A 2030-11-23 | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 0 | $0 | 146,416 (Direct) | View |